Marianne Grønlie Guren
机构: MD PhD, Oslo University Hospital
每年引用次数
引用次数
引用: 7,461
H-指数: 42
I10-指数 : 81
出版物: 182
E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Jarle Bruun , Peter W Eide , Christian Holst Bergsland , Oscar Bruck
Molecular oncology 16 ( 12) 2312 -2329
5
2022
Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients
Hartwig Kørner , Marianne G Guren , Inger Kristin Larsen , Dagny Faksvåg Haugen
European Journal of Surgical Oncology 48 ( 8) 1831 -1839
1
2022
Biomarkers for detection of exfoliated tumor cells in the peritoneal cavity in rectal cancer
Annette T Kristensen , Arne Solbakken , Stein G Larsen , Karl-Erik Giercksky
Cancer Research 74 ( 19_Supplement) 2850 -2850
2014
Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
Alison Rowsell , Samantha C Sodergren , Vassilios Vassiliou , Anne-Sophie Darlington
Gastric Cancer 26 ( 1) 167 -167
2023
Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome
Bettina A Hanekamp , Ellen Viktil , Kathinka S Slørdahl , Johann Baptist Dormagen
Strahlentherapie und Onkologie 200 ( 1) 19 -27
2024
Modeling intrapatient pharmacotranscriptomic heterogeneity with organoids derived from colorectal cancer liver metastases.
Kushtrim Kryeziu , Jarle Bruun , Peter W Eide , Seyed H Moosavi
CANCER RESEARCH 80 ( 11) 42 -43
2020
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
Stine A Danielsen , Peter W Eide , Merete Hektoen , Marianne G Guren
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Seyed H Moosavi , Peter W Eide , Ina A Eilertsen , Tuva H Brunsell
Genome Medicine 13 1 -19
14
2021
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Anne Hansen Ree , Eirik Høye , Ying Esbensen , Ann-Christin R Beitnes
Oncoimmunology 13 ( 1) 2372886 -2372886
2024
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis
Bettina A Hanekamp , Pradeep S Virdee , Vicky Goh , Michael Jones
Physics and Imaging in Radiation Oncology 31 100618 -100618
2024
Survival trends of right-and left-sided Colon cancer across four decades: a Norwegian population-based study
Julian Hamfjord , Tor Åge Myklebust , Inger Kristin Larsen , Elin H Kure
Cancer Epidemiology Biomarkers & Prevention 31 ( 2) 342 -351
13
2022
Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
Yngvar Nilssen , Morten Tandberg Eriksen , Marianne G Guren , Bjørn Møller
BMC cancer 21 1 -18
12
2021
One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison
Renu R Bahadoer , Esther Bastiaannet , Yvette HM Claassen , Marianne van der Mark
European Journal of Surgical Oncology 47 ( 7) 1651 -1660
10
2021
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
Martin P Nilsson , Christine Undseth , Per Albertsson , Monika Eidem
Acta Oncologica 62 ( 8) 897 -906
4
2023
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
Sebastian Meltzer , Anne Negård , Kine M Bakke , Hanne M Hamre
British Journal of Cancer 127 ( 12) 2227 -2233
4
2022
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016
Yngvar Nilssen , Odd Terje Brustugun , Morten Tandberg Eriksen , Marianne G Guren
BMC cancer 22 ( 1) 220 -220
4
2022
The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries.
Renu R Bahadoer , Esther Bastiaannet , Koen CMJ Peeters , Elizabeth van Eycken
Journal of Geriatric Oncology 13 ( 6) 803 -812
3
2022
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Philip Falk , Mira Severin , Åke Berglund , Marianne G Guren
Cancer Treatment and Research Communications 31 100517 -100517
2
2022
Incidence patterns of colorectal cancer in Norway 1993-2022 by age, site, and morphology.
Mari Fjørtoft Ystgaard , Tor Åge Myklebust , Jørgen Smeby , Inger Kristin Larsen
Journal of Clinical Oncology 42 ( 3_suppl) 44 -44
2024
Systemic immune response invoked by short-course oxaliplatin-based chemotherapy (FLOX) for efficacy of sequential immune checkpoint blockade (ICB; nivolumab) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)
Sebastian Meltzer , Kjersti Flatmark , Anniken J Fuglestad , Hanne M Hamre
Cancer Research 83 ( 7_Supplement) 3279 -3279
2023